Q1 2018 13F Holders as of 31 Mar 2018
-
Type / Class
-
Equity / Class B Common Stock
-
Shares outstanding
-
5.07M
-
Number of holders
-
310
-
Total 13F shares, excl. options
-
19.3M
-
Shares change
-
+118K
-
Total reported value, excl. options
-
$4.82B
-
Value change
-
+$32.4M
-
Put/Call ratio
-
1.62
-
Number of buys
-
138
-
Number of sells
-
-146
-
Price
-
$250.08
Significant Holders of BIO-RAD LABORATORIES, INC. - Class B Common Stock (BIO) as of Q1 2018
340 filings reported holding BIO - BIO-RAD LABORATORIES, INC. - Class B Common Stock as of Q1 2018.
BIO-RAD LABORATORIES, INC. - Class B Common Stock (BIO) has 310 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 19.3M shares
.
Largest 10 shareholders include BlackRock Inc. (1.83M shares), VANGUARD GROUP INC (1.75M shares), ATLANTA CAPITAL MANAGEMENT CO L L C (1.47M shares), ACADIAN ASSET MANAGEMENT LLC (805K shares), AMERICAN CENTURY COMPANIES INC (702K shares), WELLS FARGO & COMPANY/MN (675K shares), TimesSquare Capital Management, LLC (581K shares), STATE STREET CORP (535K shares), RENAISSANCE TECHNOLOGIES LLC (344K shares), and BANK OF AMERICA CORP /DE/ (342K shares).
This table shows the top 310 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.